Genomics

Dataset Information

BPTF inhibitor increases gastric cancer response to Erlotinib by epigenetically regulating c-MYC/PLCG1/pErk axis [ChIP-seq]


ABSTRACT: BPTF inhibitor increases gastric cancer response to Erlotinib by epigenetically regulating c-MYC/PLCG1/pErk axis [ChIP-seq]

PROVIDER: PRJNA823561 | ENA |

REPOSITORIES: ENA